Nature Communications · 2018 · 124 citations · 55 references
Life SciencesGeneticsOncologyCancer GeneticsGene ExpressionMolecular OncologyGene Fusions In CancerOncogenic Signaling PathwaysTumor Suppressor GenesBap1 LossMyeloid Differentiation SignalingMyeloid DysplasiaMyeloid NeoplasmsProgenitor CellsRunx1 In Hematopoietic DevelopmentRunx1-dependent Differentiation
ASXL1 mutations occur frequently in myeloid neoplasms and are associated with poor prognosis. However, the mechanisms by which mutant ASXL1 induces leukaemogenesis remain unclear. In this study, we report mutually reinforcing effects between a C-terminally truncated form of mutant ASXL1 (ASXL1-MT) and BAP1 in promoting myeloid leukaemogenesis. BAP1 expression results in increased monoubiquitination of ASXL1-MT, which in turn increases the catalytic function of BAP1. This hyperactive ASXL1-MT/BAP1 complex promotes aberrant myeloid differentiation of haematopoietic progenitor cells and accelerates RUNX1-ETO-driven leukaemogenesis. Mechanistically, this complex induces upregulation of posterior HOXA genes and IRF8 through removal of H2AK119 ubiquitination. Importantly, BAP1 depletion inhibits posterior HOXA gene expression and leukaemogenicity of ASXL1-MT-expressing myeloid leukemia cells. Furthermore, BAP1 is also required for the growth of MLL-fusion leukemia cells with posterior HOXA gene dysregulation. These data indicate that BAP1, which has long been considered a tumor suppressor, in fact plays tumor-promoting roles in myeloid neoplasms.
55
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal, Pierre Fontanillas, Jason Flannick et al. · New England Journal of Medicine · 2014 · 4.7K citations · Full text
Life Sciences, Genetics, Hematology +17
CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling
Randall J. Platt, Sidi Chen, Yang Zhou et al. · Cell · 2014 · 2.1K citations · Full text